Vismodegib exerts targeted efficacy against recurrent sonic hedgehog-subgroup medulloblastoma: results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032 - Robinson, G W; Orr, B A; Wu, G (J Clin Oncol, 2015)